Latest Breaking News On - Gt biopharma inc - Page 11 : comparemela.com

North American Morning Briefing : Stock Futures -2- - Stock market news

No companies with investment-grade credit ratings sold new bonds over the seven business days from March 9 through March 17, the first week in March without a new high-grade bond sale since 2013, according to PitchBook LCD. The market for new junk-bond. | 06:17am

British columbiaNew york stock exchangeNew yorkUnited statesNorth koreaUnited kingdomSouth koreaNorth koreanThoma bravoRaymond jamesMark milleyScience based targets initiativeBoston properties cut toMar united kingdom consumer confidenceWaitr holdings incHc wainwright co

GT Biopharma, Inc Announces $6 5 Million Registered Direct Offering Priced At Premium To Market

GT Biopharma, Inc. Announces $6.5 Million Registered Direct Offering Priced At Premium To Market - read this article along with other careers information, tips and advice on BioSpace

New yorkUnited statesCorey davisExchange commissionGlobe newswire gt biopharma incUniversity of minnesotaGt biopharma incHc wainwright coGt biopharmaNc announces 6 5 million registered direct offering priced at premium to market

GT Biopharma (GTBP) Prices 6 5M Share Direct Offering at $1/sh

GT Biopharma (GTBP) Prices 6 5M Share Direct Offering at $1/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesExchange commissionGt biopharma incHc wainwright co

2022-12-14 | NDAQ:GTBP | Press Release | GT Biopharma Inc

(2022-12-14 | NDAQ:GTBP) GT Biopharma Names Dr. Jeff Miller as Consulting Chief Medical Officer

United statesBiopharma closecurlyquoteJeff millerCorey davisMiller closecurlyquoteMichael breenAmerican society of clinical investigationMiller laboratoryGlobe newswire gt biopharma incCompany closecurlydoublequoteResearch developmentExchange commissionMasonic comprehensive cancer centerAmerican association of immunologistsAmerican society of hematologyUniversity of minnesota closecurlyquote

GT Biopharma Names Dr Jeff Miller as Consulting Chief Medical Officer

GT Biopharma, Inc. (the “Company” or “GTB”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the

United statesJeff millerCorey davisMichael breenUniversity of minnesota masonic comprehensive cancer centerAmerican society of clinical investigationMiller laboratoryGlobe newswire gt biopharma incResearch developmentExchange commissionAmerican society of hematologyAmerican association of immunologistsUniversity of minnesotaGt biopharma incCancer specialistConsulting chief medical